Auto-CPAP for treatment of OSAS in severe obese patients Source: Eur Respir J 2005; 26: Suppl. 49, 723s Year: 2005
The reversibility of hypoxemia in OSA patients is related to CPAP therapy Source: Eur Respir J 2005; 26: Suppl. 49, 112s Year: 2005
Compliance of COPD patients to their treatment Source: Eur Respir J 2003; 22: Suppl. 45, 244s Year: 2003
Effects of CPAP treatment in UARS patients comparing to OSAS patients Source: Annual Congress 2007 - Treatment options in obstructive sleep apnoea Year: 2007
Compliance index among patients with mild asthma Source: Annual Congress 2008 - Comorbid cardiovascular condition and therapy of asthma Year: 2008
Predictors of compliance with CPAP in patients with OSA and metabolic syndrome Source: Annual Congress 2009 - Continuous positive airway pressure therapy in obstructive sleep apnoea Year: 2009
Mild OSAS: Is CPAP therapy actually required for these patients? Source: International Congress 2018 – From continuous positive airway pressure (CPAP) and adherence to CPAP to asthma-COPD overlap syndrome (ACOS) Year: 2018
Laryngeal obstruction in moderate and severe obstructive sleep apnea patients requested higher CPAP level during treatments Source: International Congress 2018 – Sleep and breathing control: phenotypes Year: 2018
Effects of CPAP treatment on 6MWD in OSAS and overlap syndrome patients Source: Eur Respir J 2002; 20: Suppl. 38, 294s Year: 2002
Home-based evaluation in patients with high risk for moderate to severe OSA Source: Annual Congress 2012 - CPAP: beneficial effects on different aspects of health Year: 2012
Triple therapy for all patients with severe symptomatic COPD at risk of exacerbations Source: Eur Respir J, 53 (4) 1900147; 10.1183/13993003.00147-2019 Year: 2019
Life-sustaining treatment preferences of patients with severe COPD Source: Annual Congress 2010 - Pulmonary rehabilitation and chronic care: new developments in interventions, assessment and care Year: 2010
CPAP setting prediction in OSAS patients Source: Annual Congress 2011 - Physiology and diagnostic technology in obstructive sleep apnoea Year: 2011
Lifestyle interventions in mild and severe OSA patients Source: International Congress 2015 – Obstructive sleep apnoea, obesity, and weight loss Year: 2015
Compliance with CPAP/BiPAP treatment in obstructive sleep apnea syndrome patients Source: Annual Congress 2010 - Clinical aspects of sleep apnoea Year: 2010
Nocturnal BP pattern and cardiovascular risk in a group of patients with moderate-severe OSAS. Evaluation of the effect of CPAP treatment Source: Eur Respir J 2007; 30: Suppl. 51, 335s Year: 2007
Impact of moderate and severe exacerbations in severe COPD patients Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD? Year: 2018
Salmeterol/fluticasone therapy improves FEV1 in mild and moderate more than in severe COPD patients Source: Eur Respir J 2004; 24: Suppl. 48, 342s Year: 2004
The effect of CPAP treatment on Galectin-3 level in patients with severe obstructive sleep apnea Source: International Congress 2018 – Cardiovascular and metabolic consequences of sleep-disordered breathing Year: 2018
Eficacy of the treatment with CPAP in patients with chronic heart failure and sleep apnoea Source: Eur Respir J 2004; 24: Suppl. 48, 564s Year: 2004